Melvin Weinstein Parkinson's Foundation (MWPF)
Funded
About
The Melvin Weinstein Parkinson's Foundation (MWPF) program offers invaluable financial assistance for Parkinson's medications, including Apokyn, Xeomin, Zelapar, Duopa, Nuplazid, Tasmar, Gocovri, Tolcapone, Inbrija, Nourianz, Apomorphine, Crexont, Vyalev, and Austedo XR. Through the MWPF, eligible Parkinson's patients may receive case-by-case grants to help manage medication costs, enhancing the affordability and accessibility of essential treatments. The MWPF stands as a crucial supporter for individuals seeking to navigate financial barriers associated with Parkinson's healthcare.
Insurance requirements: Commercially insured
Enrollment Forms
Enrollment Form
Program Requirements
•Valid only for residents in the US and Puerto Rico
•Enrollment Required: Yes
•Coverage Required: No
•Needs Based: Yes
•Activation Required: No
Program Details
•Offers financial assistance for Parkinson's medication
•Patients should mail completed application form, together with verification of diagnosis (e.g. letter from doctor), verification of income (e.g. copy of last Tax Return), and explanation of expenses to: Melvin Weinstein Parkinson’s Foundation, 3419 Virginia Beach Blvd. #A35, Virginia Beach, VA 23452
•Grants are small and offered on a casebycase basis; approved patients will be offered a grant and then pay for medication until the grant is used up
•For more information, call 7573139729 or email mwparkinsons@gmail.com
Enrollment Forms
Enrollment Form